Table 2.

Cited evidence supporting additional recommendations by the National Comprehensive Cancer Network

Cited evidence	No (%) of additional recommendations (n=44)
No evidence given	16 (36)
Book chapter or review article	1 (2)
Case report or series <5 patients	2 (4)
Case series ≥5 patients	0 (0)
Phase I trial	1 (2)
Phase II trial without randomization and <50 patients	7 (16)
Phase II trial without randomization and ≥50 patients	6 (14)
Phase II trial with randomization and <50 patients	1 (2)
Phase II trial with randomization and ≥50 patients	2 (4)
Randomized, phase III trial	7 (16)
Ongoing trial	1 (2)